Rabies virus glycoprotein (RVG) can pseudotype lentiviral vectors, although at a lower efficiency to that of vesicular stomatitis virus glycoprotein (VSVG). Transduction with VSVG-pseudotyped vectors of rodent central nervous system (CNS) leads to local neurotropic gene transfer, whereas with RVG-pseudotyped vectors additional disperse transduction of neurons located at distal efferent sites occurs via axonal retrograde transport. Attempts to produce high-titre RVG-pseudotyped lentiviral vectors for preclinical and clinical trials has to date been problematic. We have constructed several chimeric RVG/VSVG glycoproteins and found that a construct bearing the external/transmembrane domain of RVG and the cytoplasmic domain of VSVG shows increased incorporation onto HIV-1 lentiviral particles and has increased infectivity in vitro in 293T cells and in differentiated neuronal cell lines of human, rat and murine origin. Stereotactic application of vector pseudotyped with this RVG/VSVG chimera in the rat striatum resulted in efficient gene transfer at the site of injection showing both neuronal and glial tropism. Distal neuronal transduction in the substantia nigra, thalamus and olfactory bulb via retrograde axonal transport also occurs after intrastriatal administration of chimera-pseudotyped vectors at similar levels to that observed with a RVG-pseudotyped vector. This is the first report of distal transduction in the olfactory bulb. The enhanced pseudotyping with this envelope should enable easier production of higher-titre pseudotyped lentiviral vectors that exhibit efficient local and dispersed neuronal transduction in the CNS.
INTRODUCTION
HIV particles produced by cells superinfected with other viruses, such as Moloney murine leukaemia virus, herpes simplex virus and vesicular stomatitis virus (VSV), display an expanded cell tropism because of the presence of heterologous envelope-incorporated surface glycoproteins (GPs). [1] [2] [3] [4] [5] This process of pseudotyping, reviewed in Cronin et al., 6 has been extensively harnessed to alter, improve and refine the cell and tissue tropism, and transduction efficiency of replication-defective gene therapy vectors based on retroviruses and both primate and non-primate lentiviruses.
The high transduction efficiency and wide cell tropism of vesicular stomatitis virus GP (VSVG)-pseudotyped lentivirus vectors has made this the standard against which other pseudotypes are compared. VSVG-pseudotyped lentiviral vectors are stable and capable of withstanding purification and concentration protocols required for their clinical use. 7 Their broad cell tropism, however, do not make them amenable for targeting gene delivery to specific disease sites, and they lack the ability to access difficult to reach sites (such as the central nervous system (CNS)) without invasive delivery methods.
Pseudotyping of lentivirus vectors with the envelope GP of the neurotrophic rabies virus (RVG) confers both neurotropism and the ability to mediate retrograde trafficking of vector particles along neuronal axons. [8] [9] [10] [11] [12] [13] [14] RVG is the most promising GP of Lyssavirus (rabies virus (RV) and rabies-related virus) origin for the targeting of neuronal cells in vitro and in vivo. 13 This presents the possibility of targeting gene therapy for neurodegenerative diseases specifically to neuronal cells. Additionally, it opens up the possibility of a noninvasive administration of the vector by targeting the peripheral sites of neuromuscular synapses to target cells of the CNS affected by such diseases as amyotrophic lateral sclerosis and spinal muscular atrophy.
One barrier to the clinical use of RVG-pseudotyped lentivirus vectors is the relatively low efficiency of transduction displayed by these vectors. HIV vectors pseudotyped with either RV racSADB19 strain or the related Mokola virus GPs showed almost fivefold lower transduction efficiency when compared with the equivalent number of VSVG-pseudotyped vector particles on the same cell types. 14 Different strains of RV and related GPs appear to pseudotype lentivirus vectors at different efficiencies. RV ERA (Evelyn-Rokitnicki-Abelseth) and CVS (Challenge Virus Standard; B2c) strains have been shown to efficiently pseudotype lentivirus vectors based on equine infectious anaemia virus (EIAV), although at a lower efficiency than VSVG. 8, 10 However, efficient pseudotyping of HIV-1-based vectors remains problematic in our hands and that of others; 11 the RV CVS (B2c substrain) pseudotypes HIV-1 vector particles with the best efficiency.
In this study we aimed to generate a chimeric envelope GP bearing the RVG receptor-binding domain that will more efficiently pseudotype HIV-1 vectors by replacing the cytoplasmic, transmembrane and extracellular stalk regions of RVG with the corresponding regions from VSVG. The pseudotyping and transduction efficiency of these new constructs was evaluated. We show that replacing the cytoplasmic region of RVG with the cytoplasmic region of VSVG resulted in higher levels of GP incorporation on the vector particles, and that this correlated with an increase in transduction efficiency. The ability of this chimera vector to transduce the CNS was also evaluated in vivo in the rat CNS.
RESULTS
Design and construction of chimeric rabies/ VSVG expression plasmids Lentiviral vectors have in the past been pseudotyped with RVG from a number of different strains of rabies viruses. The ERA strain 15 envelope GP has been used effectively to pseudotype EIAV vectors for therapeutic delivery of vascular endothelial growth factor to the SOD1 G93A mouse model of amyotrophic lateral sclerosis. [16] [17] [18] [19] In our hands, however, the ERA strain does not seem to pseudotype HIV vectors very efficiently (P Patsali and ND Mazarakis, unpublished results). Other labs have had some success using the RVG from the rabies virus PV (Pasteur vaccines) strain. 11, 13 We have had very good results using the CVS strain, particularly the B2c substrain, to pseudotype HIV-1 vectors (SM Ellison, RI Asfahani, ND Mazarakis, unpublished results). Bioinformatic analysis and sequence alignment of the C-terminus of both the ERA and CVS (B2c and N2c substrains) GP amino-acid sequences revealed a region of low sequence homology, mapping to the cytoplasmic tail and the transmembrane a-helix, compared with the rest of the protein sequence (Figure 1 ). This suggested that the differences in these regions could play a role in determining the pseudotyping efficiency of the respective strains of RVG. We were interested in generating a recombinant RVG with enhanced HIV-1 pseudotyping efficiency. To achieve this we decided to construct chimeric GP constructs replacing regions of the RVG (CVS-B2c) with corresponding regions from VSVG, known to efficiently pseudotype HIV-1 vectors.
VSVG and RVG are members of the class III viral fusion proteins. 20 They are both membrane-associated proteins possessing a single transmembrane helix toward the carboxy terminus, and an amino terminal signal peptide that gets cleaved off during post-translational processing. Both G proteins are incorporated into virus particles as trimers [21] [22] [23] [24] and mediate receptor interaction, entry and membrane fusion. The VSVG protein sequence shows low but significant sequence homology with RVG 25 and is thought to share several structural and functional properties with RVG. The structure of the VSVG extracellular domain reviewed in Roche et al. 26 has been determined both in its prefusion 24 and low pH 23 forms by X-ray crystallography after proteolytic treatment to remove disordered regions. Based on these observations we defined the extracellular portion of both VSVG and RVG as consisting of the receptor-binding domain (also mediating membrane fusion) and a less ordered stalk domain (see Figure 2b) linking it to the hydrophobic transmembrane domain as defined in Rose et al. 27 Using the PCR and splicing by overlap extension (SOE), 28 envelope protein expression plasmids were generated encoding RVG/VSVG chimeric proteins in which: (1) the cytoplasmic domain of RVG was replaced with the cytoplasmic domain of VSVG (RVG/VSVG(C)), (2) the cytoplasmic and transmembrane domains of RVG were replaced by the cytoplasmic and transmembrane domains of VSVG (RVG/VSVG(TC)) and (3) the cytoplasmic and transmembrane domains and most of the extracellular stalk domain of RVG were replaced by the corresponding region of VSVG (RVG/VSVG(STC)). Figure 2 gives details of the chimeric constructs generated.
Lentiviral vectors pseudotyped with a chimeric RVG possessing the VSVG cytoplasmic domain show increased transduction efficiency in 293T cells HIV-1 vectors, carrying a green fluorescent protein (GFP) expression cassette, pseudotyped with the VSVG, RVG and the three RVG/VSVG chimeric constructs, were produced (triplicate small-scale preparations) by co-transfection of 293T cells by calcium phosphate precipitation (see Materials and Methods). Supernatants were harvested and vector particles were concentrated and purified by ultracentrifugation through a 20% sucrose cushion. The biological titre of the vectors was determined by flow cytometry of eGFP expressing transduced 293T cells ( Figure 3a and Table 1 ). The vector particle concentration of each preparation was estimated by enzyme-linked immunosorbent assay (ELISA) for the HIV-1 P24 capsid protein. The values were used to calculate a vector infectivity value (transduction units (TU) per ng P24). None of the RVG receptor-binding domain containing constructs came close to matching the transduction efficiency of VSVG (RVG showed almost a 10-fold lower infectivity value compared with VSVG; see Figure 3b ). The TC and STC constructs showed almost complete loss of transduction. The construct in which only the cytoplasmic domain had been replaced showed a significant (P¼0.0343) but small (approximately twofold) Figure 1 Rhabdoviridae envelope glycoprotein bioinformatics sequence alignment. Alignment of the C terminal portion of RVG from the CVS-B2c, CVS-N2c and the ERA vaccine strains and VSVG from the Indiana strain. Highly conserved (shared by X75% of the sequences) residues are shaded black. Moderately conserved residues (shared by 50% of the sequences) are shaded grey. The numbering is based on the start codon being the first residue, unlike numbering in some publications that base it on the position relative to the proteolytic cleavage site after the signal peptide. Regions as defined for VSVG based on structural and biochemical studies are indicated above the sequence.
Enhanced chimeric envelope pseudotyping DCJ Carpentier et al increase in vector infectivity compared with RVG-pseudotyped vectors. Assuming B2000 molecules of p24 per HIV particle (published estimates range from 1500 to 2100), [29] [30] [31] an equivalent of B10 4 particles per pg of p24 equates to 3593 particles per TU for RVG and 1899 particles per TU for RVG/VSVG(C) ( Table 1 ).
The VSVG cytoplasmic domain increases incorporation levels of chimeric RVG into HIV-1 vector particles To determine if the changes in transduction efficiency observed for the chimeric constructs were because of an increase in the level of envelope protein incorporation into vector particles, vector preparations were analysed by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and western blot analysis. Equal numbers of vector particles were lysed in SDS-PAGE loading buffer, run on a 15% SDS-PAGE gel and blotted onto nitrocellulose membrane. Probing the membrane with an antibody to HIV-gag (aHIV-1 p55+p24+p17; Ab63917; Abcam, Cambridge, UK) confirmed that equal amounts of gag had been loaded for each sample (Figure 4ai ). Stripping and reprobing the same membrane with an antibody specific to RVG (clone 1C5) indicated that different GPs were incorporated into vector particles at different efficiencies (Figure 4aii ). Both C and STC chimeric GPs were incorporated at high levels, whereas the TC GPs appeared to be incorporated at low levels. All showed higher incorporation levels than wild-type RVG. The 1C5 antibody detected a nonspecific band in all vector preparations that was also present in control samples taken from untransfected cells that had not been transfected, making densitometry measurements difficult, as in several blots the band overlapped with the RVG band (particularly the larger wild-type RVG). We hypothesised that the antibody might be detecting a component of the bovine serum albumin present in the vector resuspension buffer; however, using unsupplemented phosphate buffered saline (PBS), lacking bovine serum albumin, failed to dispel this band.
To further confirm that the observed differences in RVG levels were not because of varying affinity of the antibody to the various constructs, we repeated the western blot and probed the membrane with an alternative antibody to RVG (SNB-1, kindly provided by Dr Edward Wright, Wohl Virion Centre, University College London, London, UK). These blots gave similar results to those done with the 1C5 antibody and only detected a minor nonspecific band present in all samples, including the control lane (Figure 4aiii ). Densitometrical analysis of three separate blots carried out on three independent sets of preparations (Figure 4b ) further supported that there was a significant difference in the incorporation levels of both C (P¼0.0184, paired two-tailed t-test) and STC (P¼0.0325, paired two-tailed t-test) GPs compared with RVG, whereas the TC GPs did not show a significant difference in incorporation levels compared with RVG.
Chimeric RVG-pseudotyped HIV-1 vectors more efficiently transduce differentiated neuronal cell lines in vitro Our results suggest that vectors pseudotyped with the chimeric RVG/ VSVG(C) construct are more efficient at transducing cells. To verify whether this is true in neuronal cells, the intended target of RVGpseudotyped vectors, we compared transduction levels of lentiviral vectors pseudotyped with the RVG/VSVG(C) chimera and wild-type RVG CVS(B2c) in three differentiated neuronal cell lines: PC12, a rat pheochromocytoma of the adrenal medulla; 32 SH-SY5Y, a thrice cloned human neuroblastoma; 33 and NSC-34, a mouse hybrid cell line displaying motor neurone-like properties created from the fusion of the neuroblastoma cell line N18TG2 and motor neurone-enriched mouse spinal cord cells. 34 Large-scale vector preparations encoding the lacZ reporter, pseudotyped with VSVG, RVG and chimeric RVG/VSVG(C), were produced and concentrated 2000-fold. Physical vector particle titres were determined by P24 ELISA and lentivirus genome quantitative PCR (see Table 2 ). The biological activity of the three different pseudotypes was determined on 293T, differentiated PC12, differentiated SH-SY5Y and differentiated NSC-34 cells (see Figure 5a ). Infectivity was calculated as TU per 10 6 genomes or TU per ng P24 for the three different pseudotypes on each of the cell lines (see Figure 5b) .
Cells transduced by equal genome copy numbers showed clear differences in LacZ-positive cells 72 h post transduction. Vectors pseudotyped with the chimeric RVG/VSVG(C) construct consistently transduced more cells than RVG-pseudotyped vectors and less than VSVG-pseudotyped vectors. This pattern was confirmed and shown to be statistically significant by quantitative analysis of the vector infectivity calculated as TU per 10 6 genomes in each of the cell lines. 293T and SH-SY5Y cells showed similar transduction patterns ( Figure 5b , top panel). Infectivity levels were slightly lower in SH-SY5Y, probably because of the more disperse cell distribution caused by growth in differentiation conditions. A similar pattern was also seen in PC12 cells grown under differentiation conditions, although overall transduction levels on these cells were much lower for all three vector pseudotypes (B10-fold lower for VSVG and B1000-fold lower for RVG and the chimera). During the differentiation process of NSC-34 cells a large number of the cells die, resulting in a very sparse cell distribution. Additionally, we observed a large number of cells dying when we used the standard transduction protocol, resulting in a very patchy cellular distribution across the tissue culture dish at the time of LacZ staining. This was potentially caused by the presence of polybrene in the transductions. The experiment was repeated without using polybrene, resulting in much lower levels of cell death; however, the transduction levels were also much lower (10-20-fold lower for RVG/VSVG(C) and RVG, and 5-fold lower for VSVG). When the data were normalised to the amount of P24 present in the vector preparations, the same general pattern was observed, although with a much lower statistical significance ( Figure 5b , bottom panel). In 293T cells the infectivity values (TU per ng P24) in one experiment were practically identical to those observed in the analysis of small-scale preparations. A second experiment however gave more variable results (giving the borderline significant P-value of 0.0528), potentially because of the greater variability in vector aliquots and to harsher pelleting and resuspension protocols used in the large-scale preparations compared with the small-scale preparations. This larger variability also resulted in the lack of statistical significance observed in SH-SY5Y and NSC-34 cells when data were normalised to P24 concentration. We analysed both P24 and vector genome content of our preparations as measures of physical particle content. Neither one of these is a good measure of the biological activity of vector preparations because of the high variability implicit in the production by transient transfection method. 35 Our numbers suggest that only 2-5% of the particles (as defined by P24 content and assuming 10 4 particles per pg of P24) contain genomic RNA molecules. This low level of genome incorporation probably reflects the larger size of the LacZ encoding genome, resulting in less efficient packaging within vector particles.
VSVG and RVG-CVS-B2c-pseudotyped vector transduction in vivo
The transduction efficiency of eGFP expressing HIV vectors pseudotyped with VSVG (Indiana strain) or RVG (CVS-B2c strain) was assessed in the brains of rats (n¼6) by intrastriatal injections with 4 ml of either vector (containing 5Â10 6 and 2.8Â10 6 transducing units, respectively). Immunohistochemical staining of sections to enhance the eGFP signal showed a distinctive difference in their pattern of transduction, with VSVG showing a localised expression within the striatum alone, whereas the RVG pseudotype expression spreading Chimeric glycoprotein-pseudotyped vectors transduce neuronal cells within the site of infection and distal areas by retrograde transport Adult rats (n¼6) were used to compare the transduction pattern of RVG-and RVG/VSVG(C)-pseudotyped HIV-1 vectors expressing eGFP from the PGK promoter following sterotaxic administration into the striatum and were killed 5 weeks after injection. The lentiviral preps used for these in vivo experiments had a biological titre of 1.66Â10 9 TU per ml in 293T cells (2000-fold concentration) for both wild-type and chimeric envelope, with P24 values of 129 and 89 mg ml -1 and infectivity values of 1.2Â10 4 and 1.8Â10 4 TU per ng P24, respectively, indicating that there are no stability issues with scaling up the chimeric pseudotype. A selection of 40 mm thick sections was stained with an anti-eGFP antibody to enhance the green fluorescence signal and evaluate the extent of transduction throughout the brains of injected rats (Figure 7 ). Possible colocalisation with neurons, astrocytes, oligodendrocytes and microglia was examined by dual staining with antibodies against eGFP in conjunction with NeuN, GFAP, Rip (data not shown) and ED1 (data not shown), respectively ( Figure 8 ). In agreement with previously published results concerning lentiviral EIAV CMV-LacZ vectors, 8, 10, 16 eGFP immunoreactivity was seen throughout the striatum for both pseudotypes (Figures 7aii and bii) . As for RVG-pseudotyped vector injections reported above, the transduced cells appeared sparse and a considerable part of immunoreactivity came from fibres rather than somas. This is true for both the pseudotypes examined. As expected, the RVG-pseudotyped vector confirmed its retrograde transport capability, and also the RVG/ VSVG(C) chimera showed this property. In fact, cells positive for eGFP were observed in the olfactory bulb, in the thalamus and in the substantia nigra in brains injected with both pseudotypes. All these sites are known to send projections to the striatum. Within the striatum the RVG pseudotype was found to transduce 42.81 ± 1.298% of striatal cells with a neuronal profile (NeuN + ), whereas the RVG/VSVG(C) pseudotype differs significantly (F (1,2) ¼1938.1, Po0.001) from the former, transducing only 14.73 ± 0.079% of neurons (Figure 8a ). Although less (37.06 ± 1.169% versus 24.31 ± 3.982%) astrocytes (GFAP + ) were transduced by the RVG/VSVG(C) pseudotype than the RVG pseudotype, this difference was found not to be significant (Figure 8b) . In some animals, staining of neuronal fibres was also observed in the globus pallidus (Figure 7aiii , arrow), most likely resulting from anterograde migration of eGFP into cell projections from its site of expression in the soma located in the striatum.
Retrograde transport efficiency of these pseudotyped vectors was compared in more detail by single immunohistochemical staining on sections obtained from the olfactory bulb and thalamus, using antibody against eGFP (Figure 7 inserts), and by dual staining, using anti-GFP and anti-TH antibodies, for the sections containing substantia nigra. Despite the presence of transduced cells from both pseudotyped vectors in the olfactory bulb, mainly but not exclusively in the mitral cell layer, a significant difference between them was noticed (F (1,4) ¼8.1883, Po0.05; Figure 9a ). In this area, RVG-pseudotyped vector transduced 4.963 ± 0.421% of DAPI + cells, whereas RVG/ VSVG(C) chimera transduced 2.036±0.9322% of DAPI + cells. Unlike areas reported above, both vectors showed approximately the same level of gene expression for the thalamus (RVG pseudotype: 0.545±0.116% of DAPI + ; RVG/VSVG(C) pseudotype: 0.497±0.103% of DAPI + ; Figure 9b ) and substantia nigra pars compacta (RVG pseudotype: 3.205 ± 0.545 eGFP + /TH + cells per animal; RVG/ VSVG(C) pseudotype: 3.125 ± 0.5 eGFP + /TH + cells per animal; Figure 9c ). Thalamic nuclei in which transduced cells could be observed were the ventromedial, ventrolateral, centromedial, the paracentral, the submedial (Figure 7) , the mediodorsal, the posterior and the parafascicular (not shown) nuclei.
DISCUSSION
Of the three chimeric constructs tested in this study, only one was found to produce pseudotyped vectors possessing higher biological activity. Replacing the RVG cytoplasmic tail with that of VSVG resulted in more RVG being incorporated per vector particle and in preparations possessing higher biological activity. It is unclear whether this increased incorporation is because of an ability of the VSVG cytoplasmic tail to preferentially localise in cholesterol-rich detergentresistant microdomains believed to be the main site of HIV particle budding. It is also unclear if this is because of a direct or indirect interaction with HIV capsid or matrix proteins, or because of the fact that the VSVG cytoplasmic tail is considerably shorter than the RVG cytoplasmic tail. Studies using Measles virus envelope proteins to pseudotype lentiviral vectors found that truncating the cytoplasmic tail increased the biological titre of preparations and increased the level of both heamaglutinin and Fusion protein incorporation into vector particles. 36 It is possible that the added steric hindrance of larger cytoplasmic tails may exclude GP molecules from being Enhanced chimeric envelope pseudotyping DCJ Carpentier et al incorporated into budding vector particles. Interestingly, in this study replacing the transmembrane domain also resulted in loss of biological activity and a drop in RVG incorporation into vector particles, whereas extending the regions replaced to the extracellular stalk rescued incorporation levels but not biological activity. This suggests some form of interaction between the transmembrane domain of VSVG and the extracellular stalk in either maintaining the stability of the protein, mediating its membrane insertion or directing its localisation to regions of HIV budding. Although every effort was made to limit the replaced region to parts of the protein not involved in the structure of the receptor-binding domain, by referring to the structural models of VSVG, [23] [24] it is possible that these regions play an important role in the biological activity, structure or multimerisation of the GPs. Our initial evaluation of the infectivity of the different constructs was done using small-scale sucrose cushion purified preparations to transduce human 293T cells. We proceeded to compare the infectivity of chimera-pseudotyped vector with RVG-pseudotyped vectors by transducing a range of neuronal cell lines from a spectrum of species (PC12; rat, SH-SY5Y; human, NSC-34; mouse) grown in conditions that induce neuronal cell differentiation using large-scale preparations. Differences in infectivity values were less clearcut than with the smallscale preparations (although they still showed the same trend), probably because of the higher variability introduced in the preparations by the harsh pelleting and resuspension protocol. These processes may result in more vector particle damage and a lower purity (because of longer and more intense centrifugation without the benefit of a sucrose cushion), resulting in a higher level of non-biologically active particle-associated P24 and genomic RNA molecules. This would affect the normalisations carried out in the in vitro experiments ( Figure 5 ). However, it is interesting to note that the TU per ng P24 was very similar between the small prep experiment and the large prep experiment (B5Â10 3 TU per ng for the chimera in 293T cells).
All pseudotyped vectors possessed considerably higher 'infectivity' values on human cells compared with rodent cells (roughly 100-to 1000-fold higher numbers of cells were transduced in 293T and SH-SY5Y compared with PC12 and NSC-34 cells). CVS-24 is a mouse-adapted rabies virus strain from which two quasispecies variants have been isolated. The N2c variant shows a stronger preference to neuronal cells in vitro and in vivo, and is more Figure 4 Comparison of GP incorporation into vector particles. (a) Western blot of purified pseudotyped vector particles on a 15% SDS-PAGE gel. Supernatant from untransfected 293T cells put through the same purification process as the particles were loaded as a background control (lane 1). Equal numbers of vector particles were loaded into all wells (lanes 2-6) based on the values of a P24 ELISA (see Table 1 ). Electrophoresed proteins were transferred onto a nitrocellulose membrane and blotted for the presence of HIV-1 gag using an antibody that binds both capsid and matrix domains of HIV-1 gag (i), as a loading control to verify that equal levels of vector particles were present in all the samples. HIV-gag proteolytic processing intermediates pr55 and p41 were detected by the antibody along with the completely processed p24 capsid and p17 matrix protein.
Membranes were blotted with two alternative antibodies detecting different epitopes of the RVG protein (1C5 (ii) and SNB-1 (iii), both specific for the receptor-binding domain). Specific bands for the RVG protein were detected migrating at B60 kDa size. A size difference was observed between the wild-type RVG and the chimeric proteins because of the difference in the size of their respective cytoplasmic domains. Images (i) and (ii) represent the same membrane that has been stripped and reprobed. (b) Quantification of the levels of GP incorporation by densitometry of triplicate independent vector production experiments and blotted with the SNB-1 antibody. Error bars show ±s.e.m. (*Po0.05 compared with RVG by paired two-tailed t-test). Table 2 ). Numbers are the average of two independent experiments each with triplicate samples (n¼6). For NSC-34 cells, one experiment was done in the presence of polybrene (n¼3) and one was done without polybrene (n¼3). In the graphs, the y axis is log 10 scale. *, ** and *** indicate levels of statistical significance.
Enhanced chimeric envelope pseudotyping DCJ Carpentier et al Enhanced chimeric envelope pseudotyping DCJ Carpentier et al pathogenic in adult mice, whereas the B2c variant has been described as preferentially replicating in nonneuronal cells and being more pathogenic in neonatal mice. 37 The in vivo results show that both wild-type RVG-and chimerapseudotyped vectors are able to efficiently transduce cells around the site of injection as well as cells in distal sites reachable by retrograde axonal trafficking of vectors. We observed differences in the affinity for neuronal and glial striatal subpopulations for the two pseudotypes. The RVG/VSVG(C)-pseudotyped vector showed a significantly lower rate of neuronal tropism compared with RVG, where approximately half of the transduced cells were neurons. Taken together with the lower, but not statistically significant, difference in the level of astrocyte transduction between the two pseudotypes, this would suggest that the increase in pseudotyping efficiency does not translate into improved neuronal transduction in vivo.
Concerning the retrograde transport properties of the two pseudotypes examined here, besides a slightly better overall efficiency of the RVG pseudotype, especially in the olfactory bulb, they were both found to be able to transduce similar distal areas. The striatum represented the ideal target of intracranial injection because of both its size and position and its extensive interconnections throughout the brain, the former because of the virtual absence of a misplacing occurrence, the latter because of the plethora of different structures that send to or receive connections from it, thus allowing accurate assay of the retrograde transport properties of pseudotyped vectors.
The olfactory bulb transduction is a new observation of retrograde transport of RVG-pseudotyped vectors via projections to ventral striatum, in accordance with published observations. 38 To our knowledge, this is the first report of such evident and defined expression of vector-carried gene in cells of the olfactory bulb after intrastriatal injection. Although most of the cells transduced in the olfactory bulb could be defined by their morphology and relative positioning as mitral cells, not all of them appear to belong to the same category, or to be tufted cells. These cells constitute the sole output of the olfactory bulb, but the finding of transduced cells possibly belonging to other categories (granule cells) raises some fascinating consideration about the connectivity in this area. However, without using specific markers for the various cytological classes mentioned above, it is impossible to make further statements at present.
One of the many hurdles to advancing virus-based gene therapy vectors into clinical trials is the relatively high cost and effort required to produce enough material to administer therapeutically active doses to any recipient organism larger than a rodent. Any advance that either increases the production levels of these vectors or makes them more efficient gene delivery vehicles would be a welcome contribution. Several strategies have been employed to simplify and optimise production methods, including establishing stable cell lines expressing components of the vectors, 39 producing vectors in alternative expression systems 40 or using alternative ways to introduce vector component expression constructs into producer cells. 41 The VSVG pseudotype has been used in many studies because of the wide tropism and good transduction levels observed in most cell types with these vectors. 19 However, its high promiscuity (capable of transducing a very wide range of cell types), potential cytotoxicity, 42 sensitivity to inactivation by human complement 43 and high immunogenicity 44 may prevent its extensive use in the clinic. For the treatment of diseases with wide pathology in the CNS, the lack of axonal retrograde transport makes delivery of VSVG-pseudotyped vectors problematic, requiring direct delivery to multiple sites within the CNS to target them. Although RVG-pseudotyped lentiviral vectors that are capable of retrograde trafficking to the CNS after intramuscular delivery have shown promise as treatments for Figure 8 Characterisation of cells transduced by RVG-and RVG/VSVG(C)-pseudotyped vectors at sites distal to the site of injection. (a) Neuronal tropism of pseudotyped lentiviral vectors in the striatum. eGFP + sections were stained using anti-eGFP antibody (Alexa488 secondary antibody, to enhance the eGFP signal) shown in green, and antibody to NeuN (Alexa594 secondary antibody, to stain neuronal cells) shown in red. Graph shows the efficiency of gene transfer of pseudotyped vectors. The ratio of eGFP + /NeuN + relative to total NeuN + cell number is plotted. ***Po0.001, significant difference between the two pseudotypes (analysis of variance (ANOVA)). (b) Glial tropism of pseudotyped lentiviral vectors in the striatum. eGFP + sections were stained using anti-GFP antibody (shown in green), and antibody to GFAP (Alexa594 secondary antibody, to stain astrocytes) shown in red. Graph shows the efficiency of gene transfer of pseudotyped vectors. The ratio of eGFP + /GFAP + relative to total GFAP + cell number is plotted. (c) Pseudotyped vectors gene expression in nigrostriatal dopamine neurons in substantia nigra (Â10 magnification: SNc, pars compacta, SNr, pars reticulata). GFP + sections were stained using antieGFP antibody shown in green, and antibody to tyrosine hydroxylase (TH; Alexa594 secondary antibody, to stain dopaminergic neurons) shown in red. Scale bars show 100 mm. Enhanced chimeric envelope pseudotyping DCJ Carpentier et al neurodegenerative diseases, 17 the difficulty of producing high-titre preparations has hindered their advancement to clinical trials. In this study we looked at whether creating a hybrid RVG protein possessing various regions of VSVG that potentially play a role in their incorporation into lentiviral vector particles would allow the production of more efficient vectors possessing higher biological activity. We found that this strategy did produce enhanced pseudotyping that should enable easier production of higher-titre pseudotyped lentiviral vectors that exhibit efficient local and dispersed neuronal transduction in the CNS.
MATERIALS AND METHODS Cells
293T cells (HEK 293T/17, ATCC CRL-11268) and NSC-34 cells were propagated in Dulbecco's modified Eagle's medium (Sigma, Gillingham, UK, D6546) supplemented with penicillin/streptomycin (Sigma, P4333), 4 mM L-glutamine (Sigma, G7513) and 10% (v/v) fetal bovine serum. For NSC-34 cells, the medium was further supplemented with non-essential amino acids (Sigma, M7145). To differentiate them, NSC-34 cells were maintained in reduced serum (1% fetal calf serum) complete medium for 4-10 days. SH-SY5Y (ECACC, Salisbury, UK, 94030304) cells were maintained in 1:1 Ham's F12 (Sigma, N4888), Eagle's minimal essential medium (Sigma, M2279) supplemented with 2 mM glutamine, 1% non-essential amino acids and 15% fetal bovine serum. Cells were differentiated in complete medium supplemented with 10 mM retinoic acid. PC12 (ECACC, 88022401) cells were grown on Collagen IV coated tissue culture flasks in RPMI-1640 (Sigma, R8758) supplemented with 10% (v/v) horse serum, 5% (v/v) fetal bovine serum and penicillin/streptomycin. PC12 cells were differentiated in complete medium supplemented with 50 ng ml -1 nerve growth factor.
Cloning of chimeric GP-expressing plasmids
Chimeric GPs were generated by PCR using a splicing by overlap extension protocol. 45 DNA fragments encoding the VSVG and RVG portions of the chimeric constructs described in Table 1 were each amplified by PCR using the proofreading enzyme Pfx (Invitrogen, Paisley, UK). The VSVG_R1 primer (5¢-CGTACGTTACTTTCCAAGTCGGTTCATCTCTATG-3¢) was used to amplify the C, TC and STC portions of the VSVG gene with the SOE_VSVG_TM/Cyt_DN (5¢-TGACATGGTGCCGAGTTGGTATCCATCTTTG CATTAAATT-3¢), SOE_VSVG_S/TM_DN (5¢-TGGGGAAAGTATAAAAGCTC TATTGCCTCTTTTTTCTTTATCATAG-3¢) and SOE_VSVG_X/S_DN (5¢-TT GTTGAAGTTTTTTTTGGTGATACTGGGCTATCCAAA-3¢) primers, respectively, using the pMD2-VSVG (provided by Luigi Naldini, Cell Genesys, San Francisco, CA, USA) plasmid as template. The primer RbG_F1 (5¢-C ATGGGTCGCGATGCAAACA-3¢) was used to amplify the RVG portion of the C, TC and STC constructs in conjunction with the SOE_RbG_TM/Cyt_UP (5¢-ATACCAACTCGGCACCATGTCATTAGGGAAAATATCAAC-3¢), SOE_RbG_ S/TM_UP (5¢-GGCAATAGAGCTTTTATACTTTCCCCAGTTCGGGAGAC-3¢) and SOE_RbG_X/S_UP (5¢-CCCAGTATCACCAAAAAAAACTTCAACAAAATC CTCAGCCTCA-3¢) primers, respectively, using the pMD-RVG-CVS24(B2C) plasmid as template. The corresponding fragments were spliced together by PCR utilising the overlapping complementary regions encoded within the primers used to amplify them. The resulting chimera gene was topo cloned using the Zero Blunt TOPO PCR Cloning kit (Invitrogen). Constructs were verified by restriction enzyme digest and sequencing, and subcloned into the pMD-RVG-CVS24 (B2c) plasmid digested with NruI and BsiWI, to replace the C terminal of the RVG open reading frame with that of the chimeric open reading frame. Correct insertion was confirmed by restriction digest and sequence analysis.
Bioinformatics and statistics
The amino-acid sequences for the RVG ERA (GenBank: AAA00219.1), CVSB2c (GenBank: AAB97691.1) and CVS-N2c (GenBank: AAB97690.1) strains, and VSVG Indiana strain (GenBank: ABD73123.1) were aligned using ClustalX software (ftp://ftp-19bmc.u-strasbrg.fr/pub/ClustalX/) using default settings. Genedoc (version 2.7.000) software (http://www.nrbsc.org/gfx/genedoc/) was used to display and shade the alignment.
Statistics were analysed and graphed using GraphPad Prism software (http:// www.graphpad.com/prism/prism.htm).
Production and purification of lentiviral vectors
Recombinant non-replicative HIV-1-based lentiviral vectors were produced using a modified transient calcium phosphate transfection protocol (Professor John Olson, University of North Carolina, personal communication) based on the standard four plasmid transfection of 293T cells. 46 Briefly, 150 mm tissue culture dishes were seeded with 1.4-1.6Â10 7 293T cells per dish. The next day, the cells were transfected with 15 mg vector plasmid (pRRLsincppt-CMV-eGFP-WPRE, pRRLsincppt-hPGK-eGFP-WPRE or pRRLsincppt-CMV-LacZ-WPRE expressing either GFP or LacZ from the CMV or human PGK promoter), 15 mg plasmid expressing the HIV-1 gag/pol gene (pMD2-LgpRRE), 3 mg plasmid expressing HIV-1 Rev (pRSV-Rev) and 5.1 mg of the plasmid expressing the appropriate envelope GP (all plasmids except pMD-RVG-CVS24(B2C), obtained from Manfred Schubert through the Addgene repository (Cambridge, MA, USA), 11 and pRRLsincppt-CMV-LacZ-WPRE (abbreviated pLV-LacZ), acquired from IM Verma through the Addgene repository, 47 were kindly provided by Professor James Uney, University of Bristol, Bristol, UK). At 16 h post transfection, media was replaced with fresh media supplemented with 10 mM sodium butyrate. At 36 h after sodium butyrate induction, vector containing media was harvested and filtered through a 45 mm filter.
For small-scale 'analytical' preparations, used for GP incorporation studies, vectors were purified and concentrated by ultracentrifugation (Beckman, High Wycombe, UK, SW-32 Ti, 82000g, 2 h) through a sucrose cushion (20% sucrose w/v, 10 mM NaCl, 20 mM Hepes (pH 7.4)) of vector containing media from a single transfected 150 mm plate, as described by Kutner et al. 48 Vector pellets were resuspended in PBS or PBS supplemented with 1% bovine serum albumin. Large-scale preparations were concentrated as described by Lamikanra et al. 49 Briefly, vector containing media from 12 transfected 150 mm plates was pooled and centrifuged overnight (Beckman, F500 rotor, 6000 g). The pellet was resuspended in PBS and repelleted by ultracentrifugation (Beckman, SW-32 Ti rotor, 68 500 g, 1.5 h) and resuspended over several hours in TSSM formulation buffer (20 mM Tromethamine, 100 mM NaCl, 10 mg ml -1 sucrose and 10 mg ml -1 mannitol). Vector preparations were stored at À80 1C.
Titration of lentiviral vectors
Biological activity of lentiviral vectors carrying the eGFP reporter gene was determined by flow cytometry. Briefly, 293T cells were seeded in 12-well plates at 5Â10 5 cells per well. At 16-24 h after seeding, the cells in a single well were quantified using a haemocytometer. Cells were transduced for 6 h with a serial dilution of the vector to be quantified in the presence of 8 mg ml -1 polybrene. At 72 h post transduction, the percentage of eGFP-positive cells was determined by flow cytometry. Biological activity of vectors carrying the LacZ reporter gene was done using an adapted protocol. At 48-72 h post transduction, cells were fixed and stained with X-gal using a b-gal staining kit (Invitrogen). The total number of foci of transduction (consisting of 1-8 LacZ-positive cells each) per well were counted manually. The values from dilutions giving between 30 and 300 foci of transduction were used to calculate the original vector titre. A similar protocol was used to determine biological activity of LacZ vectors on neuronal cells. SH-SY5Y and PC12 cells were seeded at 5Â10 4 cells per well in a 24-well plate. At 24 h after seeding, the medium was replaced with differentiation medium and cells were maintained for 7 to 8 days prior to transduction with vectors. At 72 h post transduction, LacZ-positive foci of transduction were quantified as described above.
The number of physical lentiviral particles present in a preparation was estimated using a HIV-1 P24 Antigen ELISA (RETROtek from ZeptoMetrix, Franklin, MA, USA) or by quantitative PCR using the Lenti-X qRT-PCR Titration Kit (Clontech, Saint-Germain-en-Laye, France).
Analysis of vector GP incorporation by western blot and densitometry
Equal numbers of vector particles (as determined by P24 ELISA) were lysed by boiling in 1Â Laemmli buffer (6Â; 259 mM Tris pH 6.8, 10% (w/v) SDS, 40% (v/v) glycerol, 0.6 M dithiothreitol) and run on a 12% SDS-PAGE gel. Separated proteins were transferred onto nitrocellulose membrane (Hybond-ECL, GE Healthcare, Chalfont St Giles, UK), blocked with PBS/Tween-20 (0.1% (v/v)) with 5% (w/v) milk powder) and probed with antibodies to RVG (Mouse monoclonal IC5 (Ab82460, Abcam) or mouse monoclonal SNB1 (kind gift Enhanced chimeric envelope pseudotyping DCJ Carpentier et al from Dr Edward Wright, UCL, London, UK). Antibody-recognised proteins were detected using a horseradish peroxidase-conjugated anti-mouse IgG secondary (Sigma) and ECL reagent (Pierce, Rockford, IL, USA). To control that equal levels of P24 protein were loaded membranes were stripped with Restore Western Stripping Buffer (Pierce) and reprobed with an anti-HIV-1 gag pr55+p24+p17 (Ab63917, Abcam) detected with a horseradish peroxidase-conjugated anti-rabbit IgG. Bands were quantified using ImageJ software on scanned images of exposed films as described on the web link given below; http://lukemiller.org/index.php/2010/11/analyzinggels-and-western-blots-with-image-j/.
Analysis of transduction pattern in the rat CNS All animal procedures were approved by the local ethical committee and performed in accordance with the United Kingdom Animals Scientific Procedures Act (1986) and associated guidelines. All efforts were made to minimise the suffering and the number of animals used. The animals were housed under a 12 h light/dark cycle (light phase, 1900 to 0700 hours) with food and water available ad libitum. Animals were supplied by Harlan (Blackthorn, UK). Male Wistar rats (n¼12), weighing 200-250 g at the start of the experiment, were used in this study. Before surgery, all animals were deeply anaesthetised by inhalation of a mixture of 3 l oxygen and 3.5% isoflurane (Merial, Parramata, NSW, Australia) and then received systemic analgesia. They were placed in a stereotactic frame (Taxic-6000, World Precision Instruments, Hitchin, UK) with the nose bar at 3.3 mm above the ear bars. The anaesthetic mixture was changed to 2 l oxygen and 2.2% isoflurane for the remainder of the operation. The scalp was cut and retracted to expose the skull. Craniotomy was performed by drilling directly above the target region to expose the cortex. Animals received 4.0 ml of TSSM formulation buffer, containing pseudotyped lentiviral vectors at a concentration of 90 ng ml -1 P24 protein, via a 26G needle using an infusion pump (UltramicropumpIII and Micro4 Controller, World Precision Instruments) at a flow rate of 0.2 ml min -1 over 20 min. Needle was then allowed to remain on site for an additional 5 min before slow retraction. One single injection was directed into the right striatum using the stereotactic coordinates relative to bregma: anteroposterior, 0.5 mm; mediolateral, 3.0; dorsoventral, 5.0 mm. At the completion of surgery, the skin was sutured.
Rats were killed by intraperitoneal injection of an overdose of sodium pentobarbitone, transcardially perfused with 50 ml saline (0.9% w/v NaCl) plus heparin, followed by 250 ml of 4% paraformaldehyde (Sigma Aldrich, St Louis, MO, USA) in 1Â PBS. Brains were removed and post-fixed for 4 h in 4% paraformaldehyde, followed by cryoprotection in 10% glycerol and 20% sucrose in 1Â PBS for at least 72 h. Brains were subsequently embedded and frozen in OCT (Surgipath FSC22, Leica Microsystems, Wetzlar, Germany). Coronal sections (40 mm) from the olfactory bulb, the entire striatum, globus pallidus and substantia nigra were cut using a cryostat (Leica Microsystems), mounted on poly-L-lysine coated slides and stored at À20 1C.
Immunohistochemistry
Immunohistochemistry was performed on slide mounted brain sections. Tissue was permeabilised for 1 h with 1Â PBS containing 10% donkey serum and 0.1% Triton X-100. Antibodies to EGFP (1:500, ab290, Abcam), NeuN (1:100, MAB377, Millipore, Watford, UK), DARPP32 (1:1000, ab40801, Abcam), GFAP (1:800, MAB360, Millipore), RIP (1:1000, MAB1580, Millipore), ED1 (1:100, ab31630, Abcam) and TH (1:2000, MAB318, Millipore) were diluted in the same buffer and placed on sections for 48 h at 4 1C. Sections were then blocked for 30 min prior to incubating for 3 h at room temperature with donkey anti-mouse, anti-goat or anti-rabbit secondary antibodies conjugated with Alexa fluor 488 or 594 (1:400, Invitrogen). Sections were coverslipped with anti-fade mounting medium Mowiol in the presence of 4,6-diamidino-2-phenylindole (DAPI; 0.05 mg ml -1 ) to label nuclear DNA.
Imaging and analysis
Images from single fluorescent labelled sections (olfactory bulb and thalamus) were taken under an epifluorescent microscope (Eclipse 80i, Nikon, Tokyo, Japan) equipped with a motorised stage for automated tiling of adjacent fields (Prior Scientific, Cambridge, UK). For the olfactory bulb, images were taken using Â10 objective (NA 0.45) and thalamus images were taken using Â4 objective (NA 0.2). Double fluorescent labelled sections (striatum and substantia nigra) were acquired under a confocal laser scanning microscope (TCS SP5 II, Leica Microsystems). For cell counts, a series of sections through the olfactory bulb, the forebrain and midbrain were used for immunostaining. The number of immunostained cells in each brain region was counted with a computer-assisted imaging program (WS Rasband, ImageJ, US National Institutes of Health, USA; http://imagej.nih.gov/ij/). For characterisation of striatal cells around vector injection sites, representative sections were used for double immunofluorescence histochemistry. In individual animals, the number of immunostained cells in the fields of interest (Â40, NA 0.85 objective) was counted with the imaging program. A total of four to six sections obtained from each brain region of individual animals were used for cell counts, and the average per animal was calculated.
Statistical analysis of in vivo results
Analysis of variance was used for statistical comparisons. Analysis was carried out using R: A Language and Environment for Statistical Computing (R Development Core Team, R Foundation for Statistical Computing, Austria; http:// www.R-project.org). Data are expressed as mean ± s.e.m. values.
